Human API, a health data platform offering a simple, digital way for consumers to share access to their electronic health records in real-time, raised $20 million in Series C funding.
The round includes participation from Samsung Ventures, CNO Financial Group, Allianz Life Ventures, and Moneta VC and existing investors BlueRun Ventures, SCOR Life and Health Ventures, and Guardian Life Insurance Company.
According to the company, the new funds will be used to scale new products and services that support product design, risk stratification, clinical trial recruitment, population health management, patient monitoring, and chronic disease management.
The company has developed a real-time health data network that connects, normalizes, and structures data from 85% of acute care and critical access hospitals, along with pharmacies, labs, and 300+ wearable devices and fitness apps.
The platform is used by insurance, corporate wellness, health plans, digital therapeutics, and clinical research organizations to build and deliver consumer-centric apps and services with electronic health records and personal device data from everywhere, the company said.
“What we’re seeing that’s really interesting is the majority of consumers that go through the Human API experience, that use our product for the first time, they will actually sign up and come back,” Human API Founder and CEO Andrei Pop said in a phone interview with MedCity News. “They use it because they’re interested. They have a desire to own their own health data and understand it more deeply for personal reasons.”
Founded in 2014, Human API has raised over $35 million to date, including a $10 million funding round in February 2019.
Digital Health companies raised over $10.3 billion during the first nine months of 2020, a 43% increase in funding compared to $7.2 billion raised in 9M 2019, according to the latest Mercom report.
